"human epidermal growth factor receptor type 2" trang 4 - tải miễn phí từ tailieunhanh
Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status

Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status
13    46    1
Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients

Trogocytosis-mediated expression of HER2 on immune cells may be associated with a pathological complete response to trastuzumab-based primary systemic therapy in HER2-overexpressing breast cancer patients
12    34    1
Poor prognosis of single hormone receptorpositive breast cancer: Similar outcome as triple-negative breast cancer

Poor prognosis of single hormone receptorpositive breast cancer: Similar outcome as triple-negative breast cancer
9    61    1
The expression of Dicer and Drosha in matched normal tissues, tumours and lymph node metastases in triple negative breast cancer

The expression of Dicer and Drosha in matched normal tissues, tumours and lymph node metastases in triple negative breast cancer
7    52    1
Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients

Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients
8    51    1
MTDH mediates trastuzumab resistance in HER2 positive breast cancer by decreasing PTEN expression through an NFκB-dependent pathway

MTDH mediates trastuzumab resistance in HER2 positive breast cancer by decreasing PTEN expression through an NFκB-dependent pathway
13    54    1
Circulating tumor cells in HER2-positive metastatic breast cancer patients: A valuable prognostic and predictive biomarker

Circulating tumor cells in HER2-positive metastatic breast cancer patients: A valuable prognostic and predictive biomarker
8    52    1
Alterations of the genes involved in the PI3K and estrogen-receptor pathways influence outcome in human epidermal growth factor receptor 2-positive and hormone receptor-positive breast cancer patients treated with trastuzumab-containing neoadjuvant chemotherapy

Alterations of the genes involved in the PI3K and estrogen-receptor pathways influence outcome in human epidermal growth factor receptor 2-positive and hormone receptor-positive breast cancer patients treated with trastuzumab-containing neoadjuvant chemotherapy
16    28    1
Heparan sulfate mediates trastuzumab effect in breast cancer cells

Heparan sulfate mediates trastuzumab effect in breast cancer cells
13    32    1
Clinical instability of breast cancer markers is reflected in long-term in vitro estrogen deprivation studies

Clinical instability of breast cancer markers is reflected in long-term in vitro estrogen deprivation studies
11    29    1
TRAIL and proteasome inhibitors combination induces a robust apoptosis in human malignant pleural mesothelioma cells through Mcl-1 and Akt protein cleavages

TRAIL and proteasome inhibitors combination induces a robust apoptosis in human malignant pleural mesothelioma cells through Mcl-1 and Akt protein cleavages
10    69    1
Understanding the molecular basis of EGFR kinase domain/MIG-6 peptide recognition complex using computational analyses

Understanding the molecular basis of EGFR kinase domain/MIG-6 peptide recognition complex using computational analyses
16    49    1
Computational analyses of curcuminoid analogs against kinase domain of HER2

Computational analyses of curcuminoid analogs against kinase domain of HER2
13    24    1
HB-EGF-induced IL-8 secretion from airway epithelium leads to lung fbroblast proliferation and migration

HB-EGF-induced IL-8 secretion from airway epithelium leads to lung fbroblast proliferation and migration
12    43    1
Clinicopathological characteristics and survival outcomes in patients with synchronous lung metastases upon initial metastatic breast cancer diagnosis in Han population

Clinicopathological characteristics and survival outcomes in patients with synchronous lung metastases upon initial metastatic breast cancer diagnosis in Han population
9    56    3
High score of LDH plus dNLR predicts poor survival in patients with HER2- positive advanced breast cancer treated with trastuzumab emtansine

High score of LDH plus dNLR predicts poor survival in patients with HER2- positive advanced breast cancer treated with trastuzumab emtansine
13    36    3
Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: A retrospective single-center study

Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: A retrospective single-center study
7    56    3
Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients

Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
10    18    1
Genetic and RNA-related molecular markers of trastuzumab-chemotherapy-associated cardiotoxicity in HER2 positive breast cancer: A systematic review

Genetic and RNA-related molecular markers of trastuzumab-chemotherapy-associated cardiotoxicity in HER2 positive breast cancer: A systematic review
14    19    1
The efficacy of human epidermal growth factor receptor 2 (HER2) blockade switching mode in refractory patients with HER2-positive metastatic breast cancer: A phase II, multicenter, single-arm study (SYSUCC-005)

The efficacy of human epidermal growth factor receptor 2 (HER2) blockade switching mode in refractory patients with HER2-positive metastatic breast cancer: A phase II, multicenter, single-arm study (SYSUCC-005)
8    16    1